NEW YORK--(BUSINESS WIRE)--Creative financing options, innovative business development practices and bottom-line cost savings are critical to the survival of emerging bioscience companies in today’s economic climate. To meet this need, the New York Biotechnology Association (NYBA) 18th Annual Meeting (April 20-21, 2009) will feature a special series of panels focused on the tools bioscience businesses need to thrive.
